Key result
Continuous monitoring of heart rate variability with a wearable device over two weeks revealed a significant association between cardiac autonomic dysfunction and progressive neurodegeneration in patients with multiple sclerosis.
Why the study?
Autonomic nervous system dysfunction is common in multiple sclerosis and likely precedes diagnosis, but its role in the disease remains poorly understood.
Does continuous monitoring with wearables reveal an association of cardiac autonomic dysfunction with disease severity in patients with multiple sclerosis?
Cross-Sectional (n=79)
No
Does continuous monitoring with wearables reveal an association of cardiac autonomic dysfunction with disease severity in patients with multiple sclerosis?
Continuous wearable monitoring of heart rate variability in multiple sclerosis patients reveals cardiac autonomic dysregulation associated with inflammation and neurodegeneration.
Answers are grounded in this paper and cite their sources.
Wearable HRV trend analysis detects autonomic dysregulation tied to MS inflammation and progression; leaves open its role as a biomarker.
Background Dysfunction of the autonomic nervous system is common in multiple sclerosis patients, and probably present years before diagnosis, but its role in the disease is poorly understood. Objectives To study the autonomic nervous system in patients with multiple sclerosis using cardiac autonomic regulation measured with a wearable. Methods In a two-week study, we present a method to standardize the measurement of heart rate variability using a wearable sensor that allows the investigation of circadian trends. Using this method, we investigate the relationship of cardiac autonomic dysfunction with clinical hallmarks and subjective burden of fatigue and autonomic symptoms. Results In 55 patients with multiple sclerosis and 24 healthy age- and gender-matched controls, we assessed the cumulative circadian heart-rate variability trend of two weeks. The trend analysis revealed an effect of inflammation ( P = 0.0490, SMD = -0.5466) and progressive neurodegeneration ( P = 0.0016, SMD = 1.1491) on cardiac autonomic function. No association with subjective symptoms could be found. Conclusions Trend-based heart rate variability measured with a wearable provides the opportunity for unobtrusive long-term assessment of autonomic functions in patients with multiple sclerosis. It revealed a general dysregulation in patients with multiple sclerosis.
No takes yet. Share an insight, caveat, or question.
Hilty et al. (2022) conducted a cross-sectional in Multiple Sclerosis (n=79). Progressive neurodegeneration (Multiple Sclerosis) vs. Non-progressive MS / Healthy controls was evaluated on Cardiac autonomic function (adaptive difference in HRV trend) (SMD 1.1491, 95% CI 0.4995-1.7890, p=0.0016). Continuous monitoring of heart rate variability with a wearable device over two weeks revealed a significant association between cardiac autonomic dysfunction and progressive neurodegeneration in patients with multiple sclerosis.
Synapse has enriched 10 related papers. Consider them for comparative context: